TGF-?1 affects cell-cell adhesion in the heart in an NCAM1-dependent mechanism.
Ontology highlight
ABSTRACT: The contractile property of the myocardium is maintained by cell-cell junctions enabling cardiomyocytes to work as a syncytium. Alterations in cell-cell junctions are observed in heart failure, a disease characterized by the activation of Transforming Growth Factor beta 1 (TGF?1). While TGF?1 has been implicated in diverse biologic responses, its molecular function in controlling cell-cell adhesion in the heart has never been investigated. Cardiac-specific transgenic mice expressing active TGF?1 were generated to model the observed increase in activity in the failing heart. Activation of TGF?1 in the heart was sufficient to drive ventricular dysfunction. To begin to understand the function of this important molecule we undertook an extensive structural analysis of the myocardium by electron microscopy and immunostaining. This approach revealed that TGF?1 alters intercalated disc structures and cell-cell adhesion in ventricular myocytes. Mechanistically, we found that TGF?1 induces the expression of neural adhesion molecule 1 (NCAM1) in cardiomyocytes in a p38-dependent pathway, and that selective targeting of NCAM1 was sufficient to rescue the cell adhesion defect observed when cardiomyocytes were treated with TGF?1. Importantly, NCAM1 was upregulated in human heart samples from ischemic and non-ischemic cardiomyopathy patients and NCAM1 protein levels correlated with the degree of TGF?1 activity in the human cardiac ventricle. Overall, we found that TGF?1 is deleterious to the heart by regulating the adhesion properties of cardiomyocytes in an NCAM1-dependent mechanism. Our results suggest that inhibiting NCAM1 would be cardioprotective, counteract the pathological action of TGF?1 and reduce heart failure severity.
SUBMITTER: Ackermann MA
PROVIDER: S-EPMC5647243 | biostudies-other | 2017 Nov
REPOSITORIES: biostudies-other
ACCESS DATA